周美玲（1990-），女，博士，副教授。主持和主研国家自然科学基金、四川省科技计划项目和泸州市科技计划项目等各级科研项目10余项。以第一或通讯作者发表SCI论文10余篇。获发明专利1项。获2020-2022年度西南医科大学青年科技人才培育计划。担任临床药学本科生和研究生的教学工作。

研究方向：新型药物传递系统研究，药物靶向递送系统研究

工作经历：2017年毕业于四川大学华西药学院，获理学博士学位，2017年至今在西南医科大学附属医院药学部/西南医科大学药学院临床药学教研室工作。

代表性论文：

(1) Hui Li#, Yue Feng#, Xiu Zheng#, Ming Jia#, Zhiqiang Mei, Yao Wang, Zhuo Zhang*, Meiling Zhou*, Chunhong Li*. M2-type exosomes nanoparticles for rheumatoid arthritis therapy via macrophage re-polarization. Journal of Controlled Release, 2022, 341: 16-30. (IF = 9.776)

(2) Lin Chen#, Yan Lin#, Zijun Zhang#, Ruisheng Yang, Xiaosheng Bai, Zhongbing Liu, Zhongling Luo, Meiling Zhou*, Zhirong Zhong*. A novel dual-prodrug carried by cyclodextrin inclusion complex for the targeting treatment of colon cancer. Journal of Nanobiotechnology, 2021, 19:329. (IF = 10.435)

(3) Rongtao Zhang#, Siqiong Wu#, Qian Ding#, Qingze Fan, Yan Dai, Shiwei Guo, Yun Ye, Chunhong Li*, Meiling Zhou*. Recent advances in cell membrane-camouflaged nanoparticles for inflammation therapy. Drug Delivery, 2021, 28(1):1109-1119. (IF = 6.419)

(4) Jian Li#, Jun Wei#, Yujie Wan#, Xingjie Du#, Xiaosheng Bai#, Chunhong Li, Yan Lin, Zhongbing Liu, Meiling Zhou*, Zhirong Zhong*. TAT-modified tetramethylpyrazine-loaded nanoparticles for targeted treatment of spinal cord injury. Journal of Controlled Release, 2021, 335:103-116. (IF = 9.776)

(5) Tiantian Liang#, Rongtao Zhang#, Xianbin Liu#, Qian Ding, Siqiong Wu, Chunhong Li, Yan Lin, Yun Ye, Zhirong Zhong*, Meiling Zhou*. Recent advances in macrophage-mediated drug delivery systems. International Journal of Nanomedicine, 2021, 16:2703-2714. (IF = 6.4)

(6) Xianbin Liu#, Tiantian Liang#, Rongtao Zhang#, Qian Ding, Siqiong Wu, Chunhong Li, Yan Lin, Yun Ye*, Zhirong Zhong*, Meiling Zhou*. Iron-based metal-organic frameworks in drug delivery and biomedicine. ACS Applied Materials & Interfaces, 2021, 13(8):9643-9655. (IF = 9.229)

(7) Yan Lin#, Yujie Wan#, Xingjie Du#, Jian Li#, Jun Wei, Ting Li, Chunhong Li, Zhongbing Liu, Meiling Zhou*, Zhirong Zhong*. TAT-modified serum albumin nanoparticles for sustained-release of tetramethylpyrazine and improved targeting to spinal cord injury. Journal of Nanobiotechnology, 2021, 19(1):28. (IF = 10.435)

(8) Yunlong Wang, Zhongbing Liu, Ting Li, Lin Chen, Jiayao Lyu, Chunhong Li, Yan Lin, Na Hao, Meiling Zhou*, Zhirong Zhong*, Enhanced therapeutic effect of RGD-modified polymeric micelles loaded with low-dose methotrexate and nimesulide on rheumatoid arthritis. Theranostics, 2019, 9(3):708-720. (IF = 8.063)

(9) Meiling Zhou, Jianbo Li, Chunhong Li, Ling Guo, Xinyi Wang, Qin He, Yao Fu*, Zhirong Zhang*, Tertiary amine mediated targeted therapy against metastatic lung cancer, Journal of Controlled Release, 2016, 241: 81-93. (IF = 7.786)

代表性科研项目：

1．基于MPDA的多功能纳米递药系统靶向诱导DC成熟抑制乳腺癌转移及其机制研究，国家自然科学基金，主持

2. 一种基于红细胞膜仿生修饰的G3-C12肽导向的新型肾靶向纳米载药系统的构建及抗慢性肾病研究，四川省科技计划项目，主持

3．急性胰腺炎靶向的中性粒细胞膜仿生修饰的新型纳米递药系统研究，泸州市科技计划项目，主持

4．巨噬细胞膜包裹的载槲皮素PLGA纳米粒靶向治疗急性肝损伤，西南医科大学重点项目，主持

单位：西南医科大学附属医院药学部/西南医科大学药学院临床药学教研室

E-mail: meilzhou@163.com